BioWorld Asia

April 27, 2005

TKT Absorbed For $1.6B As Shire Fattens Pipeline

In what could be the largest acquisition of 2005 - and certainly the largest so far - Shire Pharmaceuticals Group plc has nabbed Transkaryotic Therapies Inc. in a deal worth $1.6 billion. (BioWorld International) Read More

£32.8M For Alizyme Earmarked For Renzapride, Cetilistat Work

Blocking Toxins Could Defeat Bacterial Antibiotic Resistance

Genmab Moves Zanolimumab Into Lymphoma Pivotal Study

Tight Agrobiotech Rulings Provoke German Lawsuit

Cash Squeeze Could Hamper Finnish Personalized Medicine

Microdosing Guidelines From FDA Might Reduce Time, Waste

Europe Pressures Syngenta On Testing, Containing Bt10

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 22, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 22, 2025.

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...